Net Sales are expected to increase by 29 percent Y-o-Y (up 30.5 percent Q-o-Q) to Rs. 745.1 crore, according to Edelweiss.
Edelweiss has come out with its fourth quarter (Jan-March’ 18) earnings estimates for the Pharma sector. The brokerage house expects Natco Pharma to report net profit at Rs. 315.3 crore up 78.5% year-on-year (up 39.3% quarter-on-quarter).
Net Sales are expected to increase by 29 percent Y-o-Y (up 30.5 percent Q-o-Q) to Rs. 745.1 crore, according to Edelweiss.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 68.9 percent Y-o-Y (up 37.8 percent Q-o-Q) to Rs. 407.1 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More
